Found: 7
Select item for more details and to access through your institution.
Mucocutaneous Manifestations of Recreational Drug Use.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 2, p. 281, doi. 10.1007/s40257-023-00835-y
- By:
- Publication type:
- Article
HyBryte™ use in early-stage cutaneous T-cell lymphoma.
- Published in:
- Frontiers in Drug Discovery, 2023, p. 1, doi. 10.3389/fddsv.2023.1298453
- By:
- Publication type:
- Article
Compatibility study of topical 0.25% hypericin (HyBryte<sup>TM</sup>) application in subjects with mycosis fungoides: Results of the HPN‐CTCL‐02 study.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 4, p. 1109, doi. 10.1002/jvc2.442
- By:
- Publication type:
- Article
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 643, doi. 10.1007/s13555-022-00681-6
- By:
- Publication type:
- Article
Characteristics of Dermatology Residency Program Morbidity and Mortality Conferences: A Survey of Program Directors.
- Published in:
- JMIR Dermatology, 2023, v. 6, n. 1, p. 558, doi. 10.2196/45194
- By:
- Publication type:
- Article
A cross‐sectional analysis of Google images of mycosis fungoides: is dark skin adequately represented?
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 8, p. e426, doi. 10.1111/ijd.16537
- By:
- Publication type:
- Article
Itch on YouTube: a cross‐sectional analysis.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 4, p. e226, doi. 10.1111/ijd.16123
- By:
- Publication type:
- Article